2m 2m 2m 2m 2m 2m 2m
ROYAL PHARM -A (RPRX)
NASDAQ
$58.08+$0.92 (+1.61%)
Price as of Oct 02, 2026 7:30 PM EDT- $25.5BMarket Cap
- 61.54%1-Year Change
- BiotechnologyIndustry
ROYAL PHARM -A (RPRX)
$58.08+$0.92 (+1.61%)
Earnings Score
Valuation | RPRX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | RPRX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 13.60% | ||
12-Month Momentum | 76.31% | ||
3-Month Risk Adjusted Momentum | 133.16% | ||
12-Month Risk Adjusted Momentum | 350.55% |
True Yield
Valuation | RPRX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | 1.63% | ||
Net Buyback Yield | 1.29% | ||
Net Debt Paydown Yield | -0.03% |
Financial Health Score
Valuation | RPRX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 7 |